| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/27/2002 | WO2002005844A3 Protein complex serving as a vehicle for orally administerable medicaments |
| 06/27/2002 | WO2002000882A3 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 06/27/2002 | WO2001097838A3 Adjuvants and processes to induce a specific type of immune response |
| 06/27/2002 | WO2001089509A3 Method of treating hiv-1 disease |
| 06/27/2002 | WO2001087938A3 Polynucleotide sequence encoding a putative cell adhesion molecule |
| 06/27/2002 | WO2001085949A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 06/27/2002 | WO2001081361B1 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 06/27/2002 | WO2001073027A3 Compositions and methods for therapy and diagnosis of colon cancer |
| 06/27/2002 | WO2001070978A3 Polypeptides and nucleic acids encoding same |
| 06/27/2002 | WO2001044816B1 Conformational and topological protein regulation |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | WO2001035994A3 Chitosan induced immunopotentiation |
| 06/27/2002 | WO2001030393A8 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2001012217A9 Therapeutic antibody against muc-1 antigen and methods for their use |
| 06/27/2002 | WO2000078787A9 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE) |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | WO2000064925A9 Method of inhibiting leukocyte adhesion to fibrinogen |
| 06/27/2002 | WO2000063394A9 A polypeptide having amidolytic activity for a serpin |
| 06/27/2002 | US20020082780 Natural, anti-bacterial, anti-virus, anti-herpes cream |
| 06/27/2002 | US20020082411 Immune mediators and related methods |
| 06/27/2002 | US20020082402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/27/2002 | US20020082400 Immunoconjugate for use in human therapeutics and diagnostics |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections |
| 06/27/2002 | US20020082386 Monoclonal antibody for use in the detecion and prevention of bacillus anthracis infections |
| 06/27/2002 | US20020082385 Protein for use in dietetics and the treatment of diabebtes |
| 06/27/2002 | US20020082297 Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
| 06/27/2002 | US20020082296 Use in modulation and immunoregulation of an immune response towards infection with mycobacteria in humans and animals; anti-tuberculosis treatment; arthritis treatment; diagnosis |
| 06/27/2002 | US20020082235 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082224 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 06/27/2002 | US20020082217 Synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082197 Method for treating a mucus secretion |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081680 Fusion protein for use in the diagnosis and treatment of tumors |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081647 Apoptosis inducing molecule ii and methods of use |
| 06/27/2002 | US20020081642 Serodiagnostic test; for use in the detection of microorganisms in sample |
| 06/27/2002 | US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 06/27/2002 | US20020081623 Chemotactic cytokine |
| 06/27/2002 | US20020081609 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/27/2002 | US20020081608 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of cancer |
| 06/27/2002 | US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081573 Kit for detecting a respiratory syncytial virus in sample |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081566 Hiv protein epitopes immunologically homologous to hla |
| 06/27/2002 | US20020081329 Matrix of saponin preparation, a sterol, a phospholipid and a metal chelating moeity that can bind a protein or polypeptide |
| 06/27/2002 | US20020081320 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 06/27/2002 | US20020081317 Bacteria rendered non-pathogenic having altered DNA adenine methylase activity, genetically engineered to express a heterologous antigen such as immunogenic antigen of a virus, protozoa, parasite or fungi |
| 06/27/2002 | US20020081316 Vector and recombinant vaccines made therefrom useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease |
| 06/27/2002 | US20020081313 Antibodies; protecting animals from diseases caused by filariids; fluorescent or colorimetric tagged enzyme substrate |
| 06/27/2002 | US20020081312 For the diagnosis and immunization of humans and animals against gastrointestinal disorders |
| 06/27/2002 | US20020081311 Improving gut barrier function and/or competitively excluding pathogens from binding to and invading epithelial cells; adhesin component derived Lactobacillus species such as L. salivarius |
| 06/27/2002 | US20020081310 Apoptosis-related compounds and their use |
| 06/27/2002 | US20020081308 Treatment of Pythium insidiosum infections; animal model for evaluating Pythium insidiosum vaccines |
| 06/27/2002 | US20020081307 Verotoxin b subunit for immunization |
| 06/27/2002 | US20020081304 Type f botulinum toxin and use thereof |
| 06/27/2002 | US20020081303 Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders |
| 06/27/2002 | US20020081300 Administering the combination of anti-glutamic acid decarboxylase (anti-GAD) antibody and anti-insulin antibody in amount effective to treat or prevent diabetes |
| 06/27/2002 | US20020081299 Hair cell disorders |
| 06/27/2002 | US20020081297 Co-administering to the mammal a recombinant virus comprising a transgene and an immune modulator which inhibits the formation of neutralizing antibodies to the recombinant virus |
| 06/27/2002 | US20020081296 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | US20020081294 Co-administering effective amounts of tissue plasminogen actiator (tPA) and ati-CD18 antibody to mammal until about three to five hours after the onset of focal ischemic stroke to increase cerebral blood flow |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/27/2002 | US20020081277 Methods and compositions for enhancing the immunostimulatory effect of interleukin-12 |
| 06/27/2002 | US20020081276 Gene therapy utilizing hematopoietic stem cells, lymphoid progenitor cells and/or myeloid progenitor cells which are genetically modified to provide a gene that is expressed in these cells and their progency after differentiation |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432047A1 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431740A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | CA2431446A1 High affinity antibodies |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2429519A1 Novel human secreted proteins and polynucleotides encoding the same |
| 06/26/2002 | EP1216714A1 Cellular and serum protein anchors and conjugates |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216303A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216301A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216056A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 06/26/2002 | EP1216055A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 06/26/2002 | EP1216054A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 06/26/2002 | EP1216053A2 Influenza vaccine |
| 06/26/2002 | EP1140168B1 Vaccination against cancer |
| 06/26/2002 | EP0764029B1 Proteinaceous adjuvants |